Rubric Capital Management LP Cuts Position in Proto Labs, Inc. $PRLB

Rubric Capital Management LP decreased its holdings in shares of Proto Labs, Inc. (NYSE:PRLB) by 56.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 486,400 shares of the industrial products company’s stock after selling 636,938 shares during the period. Rubric Capital Management LP’s holdings in Proto Labs were worth $27,735,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Quantinno Capital Management LP boosted its position in shares of Proto Labs by 98.9% in the 1st quarter. Quantinno Capital Management LP now owns 27,716 shares of the industrial products company’s stock worth $1,580,000 after purchasing an additional 13,781 shares in the last quarter. Lazard Asset Management LLC increased its position in Proto Labs by 31.4% during the 1st quarter. Lazard Asset Management LLC now owns 99,333 shares of the industrial products company’s stock valued at $5,664,000 after buying an additional 23,759 shares in the last quarter. Renaissance Technologies LLC increased its position in Proto Labs by 5.4% during the 1st quarter. Renaissance Technologies LLC now owns 520,251 shares of the industrial products company’s stock valued at $29,665,000 after buying an additional 26,700 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Proto Labs by 0.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 463,780 shares of the industrial products company’s stock valued at $26,445,000 after buying an additional 3,162 shares during the last quarter. Finally, Sei Investments Co. purchased a new position in Proto Labs during the first quarter valued at $503,000. Institutional investors own 84.54% of the company’s stock.

Insider Activity

In other news, Director Sven Wehrwein sold 2,000 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the transaction, the director owned 32,505 shares in the company, valued at $2,511,986.40. This represents a 5.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael R. Kenison sold 16,030 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the sale, the insider owned 18,683 shares of the company’s stock, valued at $1,298,281.67. This trade represents a 46.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 25,663 shares of company stock valued at $1,804,727 in the last ninety days. Insiders own 1.30% of the company’s stock.

Proto Labs Price Performance

Shares of PRLB opened at $77.84 on Tuesday. The firm has a market capitalization of $1.85 billion, a P/E ratio of 73.43 and a beta of 1.38. Proto Labs, Inc. has a one year low of $38.62 and a one year high of $83.15. The business has a fifty day moving average of $76.72 and a 200 day moving average of $66.23.

Proto Labs (NYSE:PRLB) last posted its earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. The company had revenue of $139.34 million for the quarter, compared to the consensus estimate of $135.31 million. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.Proto Labs’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.33 earnings per share. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Analysts expect that Proto Labs, Inc. will post 1.37 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on PRLB shares. Benchmark boosted their target price on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Zacks Research lowered Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 3rd. Wall Street Zen cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th. Finally, Weiss Ratings upgraded shares of Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, July 17th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $65.33.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.